Lilly cut drug R&D cycle by 5 years
Eli Lilly reduced its drug development cycle from 11 years to around 6, giving it a substantial competitive advantage in patent-protected market time.
Snapshot · The Prof G Pod with Scott Galloway
Why People Are Losing Faith in Healthcare
Explore episode
Jun 4, 2026
Where this was said
Lilly's Competitive Advantage: Bet Early, Move Fast, Execute Well
At 34:30 · chapter starts 31:10
Galloway frames the question bluntly: Lilly's stock is up fivefold in five years and is worth more than J&J, Pfizer, and Merck combined. What's the secret? Ricks identifies three factors. First, capital allocation: Lilly committed to GLP-1s in 2018, when the obesity drug market was considered a non-market — the bad history of fen-phen and earlier failures had scared everyone off. Lilly bet anyway because the biology was compelling. Second, speed: when Ricks became CEO, it took Lilly 11 years from invention to market — longer than the remaining patent life of the drug. They've since cut that by five years, giving them a decisive edge over rivals who haven't. Third, culture: Lilly has never had a major merger, is based in Indianapolis rather than a biotech hub, has fewer than 50,000 employees, and maintains a Midwest nice ethos where senior leaders know each other and can solve problems without committee meetings. Ricks frames the overall philosophy as going where others won't: 'By the time a medicine market is big, it's basically too late to invest.'
How Lilly Became Worth More Than J&J, Pfizer, and Merck Combined
Lilly bet on GLP-1s in 2018 when nobody else was — obesity was considered a non-market. Combined with a 5-year cut in R&D cycle time and a singular Midwestern execution culture, those three factors compounded into a trillion-dollar market cap and fivefold stock return.
Lilly stock up 5x in 5 years
Eli Lilly's stock has risen fivefold over the past five years, making it the first healthcare company to achieve a trillion-dollar market capitalization.
Similar snapshots
80% of time above the fold
Focus 80% of your landing page design effort on the hero section — the first thing visitors see when they open the website.
Hero section carries full message
The hero section must convey the product's complete value proposition on its own, so visitors instantly understand what it is.
First couple of seconds matter most
Visitors decide whether to stay or leave within just a few seconds, so immediate clarity is essential on any landing page.
Pain-point headline drives conversion
Highlighting time savings, money savings, or a painful problem solved in the headline and subheading is the core conversion lever.
Big CTA essential above the fold
A prominent call-to-action must accompany the headline and subheading in the hero section to capture visitor intent immediately.
$25K/month revenue
Avnish's solopreneur business reached $25,000 per month in revenue using a community-driven, zero-ad-spend marketing strategy.
15 months to $25K/month
Avnish scaled his business from zero to $25K/month in just 15 months using a single core marketing strategy.
Zero marketing spend
Avnish acquired thousands of users without spending any money on marketing, relying entirely on Reddit and Facebook groups.
Single thousands to tens of thousands of users
One specific Reddit or Facebook post was responsible for taking Avnish's user base from single thousands to tens of thousands.
